In vivo enzymology is not widely studied due to the lack of a well-adapted technology. We have developed a system that allows local and long-term spectrophotometric assays in brain tissue of live animals. It utilizes a miniaturized optical probe consisting of a multibarrel micropipette for reagent injections and optical fibers for light absorption measurements. We have applied this system to the colorimetric determination of brain acetylcholinesterase activity in rats. The reproducibility of the assay was demonstrated by repetitive assays over 24 hr, its specificity was established through the use of a highly specific organophosphorus inhibitor, and the activities measured in different brain areas agreed with the known distribution of acetylcholinesterase. No electroencephalographic abnormalities and no change in vigilance level were observed in the experimental animals. This methodology should prove to be useful for the colorimetric measurement of different enzymes or metabolites in various organs.
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Our knowledge about brain chemistry comes mainly from postmortem biochemical assays. Many analytical methods have been developed for the determination of biologically active brain compounds, metabolites, and enzymes. These methods include fluorometry, radioenzymatic assays, radioimmunoassays, advanced gas chromatography, mass fragmentography, and high-performance liquid chromatography. All are very sensitive and can detect picogram levels of compounds but are not suitable for making physiological measurements due to the limitations imposed by postmortem analysis (1) . Moreover, the significance of the measurements is often doubtful because death promotes the disappearance or accumulation of many metabolites.
These major limitations stimulated the development of in vivo methods, mainly the push-pull cannula technique (2, 3), brain dialysis (4) , and electrochemical detection (5) . The push-pull cannula and in vivo brain dialysis are efficient techniques but need perfused liquid and, consequently, sample dilution, which decreases the sensitivity of the detection method and implies a time-delayed measurement. These methods are mainly used in analysis ofbiogenic amines but are rarely employed for enzymatic determinations. Voltammetry is a direct and fast analytical method that allows in vivo monitoring of monoamine derivatives with a very high anatomical specificity, but the specific identification of these compounds is very complex because their redox potentials overlap.
The lack of reliable methods for enzymatic detection in vivo led us to develop a technology for direct and localized measurement of enzymatic activity in intact animals. Many enzymatic assays can be performed with photometric methods; therefore, we sought a means of carrying out colorimetric reactions directly inside the brain. In order to follow a color reaction, we designed a spectrophotometer that utilizes a miniaturized optical probe implanted in situ.
Here, we report the use of this methodology to measure brain acetylcholinesterase (AcChoEase; EC 3.1.1.7) activity in anesthetized rats (for short-term measurements) and in unanesthetized, restrained rats (for long-term measurements). This enzyme was chosen for several reasons: it can be measured by the colorimetric method of Ellman et al. (6) with good specificity and little interference by other cholinesterases; its distribution in the central nervous system is well known (7) (8) (9) (10) ; and it can be irreversibly inhibited by a highly specific organophosphorus compound, methylphosphonothioate (MPT) (11, 12 
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Pneumatic System. Solution injections were performed with a three-module pneumatic pump (PPM2, Medical Systems, Great Neck, NY), which generated pressure pulses ranging from 10 msec to 5 sec under 2 bars (1 bar = 100 kPa) (nitrogen).
Ellman Reagent. 5,5'-Dithiobis(2-nitrobenzoic acid) (15 mM) and acetylthiocholine (15 mM) (both Sigma products) were dissolved in an isotonic phosphate buffer (pH 7.2). This reagent was 15 times more concentrated than in the original method of Ellman et al. (6) .
Calibration. Absorbance calibration was performed with riboflavin solutions (Sigma) diluted (2-6 mg/ml) in saline (0.9% NaCl), giving final absorbances ranging from 30 to 90 absorbance units/cm at 450 nm. Calibration of each injected volume vs. the duration of pressure pulses was achieved through the use of tritiated water added to the riboflavin solution (1 ,Ci/ml; 1 Ci = 37 GBq).
Cholinesterase Inhibitor. MPT was synthesized according to Ley and Sainsbury (13) (14)].
For long-term experiments, rats were surgically prepared. A 3-mm hole was drilled in the skull for subsequent probe implantation and sealed with trepanation wax. Cortical electrodes were implanted in the frontal, parietal, and occipital cortices for electroencephalographic (EEG) recording. All electrodes were soldered to a connector cemented to the skull with two anchor tubes for further chronic immobilization. Four days after surgery, rats were placed daily in the stereotaxic frame using anchor points for experimental adaptation. One week later, the optical probe was implanted and the electrodes were connected to an eight-channel polygraph (REEGA VIII, Alvar, Paris) in order to follow the cerebral electrical activity and the state of vigilance during the assay.
Data Analysis. The photomultiplier signal was digitized at a 4-Hz sampling rate with a data-acquisition system (Hewlett Packard 3421A). Absorbance and slope calculations were processed in a microcomputer (Hewlett Packard 86B).
RESULTS AND DISCUSSION
Optical Properties of the System. The first question to be addressed was whether the miniaturized probe could be used as a spectrophotometer. Indeed, it measured retrodiffused light and not transmitted light as in a classical spectrophotometer, and since both optical fibers were situated on the same side, the optical-pathway geometry was not directly controlled. We investigated the optical properties of the probe with injections of riboflavin solutions of known optical density. The Proc. Natl. Acad. Sci. USA 84 (1987) Proc. Natl. Acad. Sci. USA 84 (1987) 8147 between the absorbance and the optical path length). This "equivalent optical path" is dependent on brain mechanical properties at the measurement site, which was reflected in slope variations depending on the brain location measured. In practice these equivalent optical paths ranged from 40 to 100 ,um and remained stable in a defined structure. At first sight, the injected volume would seem an important parameter controlling the optical path. Fig. 2b illustrates the dependence of Aprobe on the injection volume. The Aprobe values rose steadily and reached a plateau between 20 and 100 nl. For larger volumes, reproducibility decreased, probably due to mechanical alterations at the assay site. Consequently, we chose a standard injection volume of 60 nl. Under these experimental conditions, the problem of injection volume was minimized by the plateau effect; the reproducibility of Aprobe measurements, despite the uncontrollable small injection-volume variations, was optimal, as demonstrated by the stability of the measurements in Fig. 2b .
These results define the physical properties of the probe. It is known that visible light penetrates brain tissue to a substantial depth (15) , and so we can postulate that a fraction .0.8. The injection creates a small space at the probe extremity. We observed an artifactual peak between 2 and 5 sec even with saline solution. This peak probably results from the mechanical deformation of the measurement site. Subsequently, the solution diffuses in the neuronal tissue and the initial optical geometry is recovered. The linear relationship between Aprobe and Areal shows that the measurement site should be considered as a homogeneous system with an equivalent optical path that accounts for the permeation properties of the dye in each neuronal site. The miniaturization of the apparatus imposed a very short equivalent optical path and required the use of high-absorbance solutions (up to 20 absorbance units/cm). In order to obtain a signal/noise ratio of >10, we had to concentrate the enzymatic substrate (15 times the normal Ellman reagent; see legend to Fig. 3) . Elimination of reactants and products was necessary to allow repeated measurements. Fortunately, we observed a slow and progressive decrease of Aprobe due to the elimination of dye by cerebral blood flow.
Brain (6) is based on the coupling of two reactions. Acetylthiocholine, used as a substrate, is hydrolyzed by AcChoEase to produce thiocholine; then activity is measured by following the increase of yellow color (thionitrobenzoate anion) produced from the reaction of thiocholine with 5,5'-dithiobis(2-nitrobenzoic acid). Since these reactions are performed at pH 7.2 and the reagents are presumed to be nontoxic, this enzymatic assay could be compatible with in vivo techniques. Therefore, it was possible to use it with our photometric method. We injected the Ellman reagent inside a brain structure and followed the rate of color production with the specially designed optical probe, as shown in Fig. 3 .
After reagent injection in striatum (caudate-putamen complex), we observed a rapid and linear increase of Aprobe, which reached a maximum and then slowly decreased. At two different substrate concentrations, the curve ( Fig. 3 ; caudate-putamen) showed the same initial slope and a maximum that depended upon the concentration. The first phase of the curve should be considered as the most important. It is linear and the initial slope is not dependent on substrate concentration (15 or 30 mM); thus, it reflects the enzyme steady-state reaction and can be used for activity determination. Furthermore, it shows that no significant excess-substrate inhibition occurred in spite of the high substrate concentrations used. In the nonlinear increasing phase, the apparent rate of reaction decreases because of the disappearance of the reactants imposed by consumption of substrate and by diffusion of dye and substrate in the neuronal tissue. The maximum of the curve corresponds to equal rates of reaction and dye removal. The decreasing phase of the curve results from elimination ofthe formed dye. The rate of removal varies with the site of injection and seems to be correlated with the local cerebral blood flow. In live animals, the time to reach the starting baseline level is constant, in a defined structure, and varied from 5 to 15 min. In dead animals, a very slow diffusion allows the return to baseline only after a time delay >1 hr. In practice, repeated measurements can be performed after the return to the baseline level in order to avoid mechanical local lesions due to the effects of cumulative injected volumes.
From the initial slope (AAprobe-min-1) of the curve, the enzyme activity (mol liter-'min-') can be estimated from the formula activity = slope 13 ,000 x p where p (cm) is the equivalent optical path measured with riboflavin and 13,000 (litermol-'cm-1) is the extinction coefficient of the yellow thionitrobenzoate anion at 450 nm (6). Depending on the structure where the probe was implanted, marked differences were observed in the initial slopes (Fig. 3) . Caudate-putamen complex exhibited the steepest slope when compared with cortex and globus pallidus, in agreement with the known AcChoEase activities in these structures (7) (8) (9) (10) .
The specificity of AcChoEase determination was verified by using MPT, a highly specific and irreversible inhibitor of the enzyme. MPT covalently binds the serine residue of the AcChoEase active site (16) . A local injection of as little as 9 fmol of MPT induced a decrease of the initial slope (Fig. 4a) . Cumulative MPT injection (60 nl each 15 min) promoted a progressive disappearance ofenzyme activity. Fig. 4b , which summarizes these successive inhibitions, shows that the 50% inhibition dose was about 8 fmol in the explored site. The residual activity that was observed could have resulted from soluble extracellular AcChoEase (17) or from other cholinesterases, which have a low turnover rate for hydrolysis of acetylthiocholine [about 1:100 for butyrylcholinesterase vs. AcChoEase (6) ]. After MPT inhibition in a site, subsequent assays show that the inhibition rate of MPT is constant and demonstrate that we are measuring the activity of the immobilized enzyme that is bound to the membranes. However, we do not know whether or not the intracellular enzymes are monitored directly.
Brain electrical activity was recorded in unanesthetized rats during a 24-hr period of repetitive assays, in order to look for neurologic side effects. EEG recordings (Fig. 5) show that no cortical abnormalities (paroxysmal events or slowing) occurred after reagent injection. Further, when the assay was performed during slow-wave sleep or sleep with spindles, no arousal reaction was observed and no EEG disturbances were noted (Fig. 5 , EEG recordings at bottom). The harmlessness of the assay was corroborated by the lack of behavioral alterations in the following days. Repetitive AcChoEase measurements were performed at the same site with a time delay of about 1 hr. They demonstrated the reproducibility of the method (Fig. 5) . For 20 assays, the relative standard deviation was only 8%.
CONCLUSIONS
The results demonstrate that our optical probe allows highly localized colorimetric measurements in the brain of live animals. Application to the colorimetric determination of AcChoEase activity demonstrated the specificity and reproducibility of our method. The extension of this method to other colorimetric enzymatic assays can be considered. These assays should be performed in physiological condi- tions of pH and temperature, on crude extracts; they should induce sufficient and relatively fast absorbance variations; and the reactants should not have neurotoxic effects. These conditions are the restricting factors ofthis technology. Thus, enzymes that could theoretically be assayed include monoamine oxidase with kynuramine (18), indoleamine 2,3-dioxygenase according to the procedure of Shimizu et al. (19) , and cathecol O-methyltransferase with hydroxylamine (20) . Fluorometric assays could also be considered, with a few modifications of the presented system. This in vivo spectrophotometric method exhibits some remarkable advantages. The measurement is direct and in real time as in voltammetry. It offers the specificity of push-pull cannulas and is only limited by the specificity of the assay reagents. The sensitivity is improved when compared with in vitro calorimetric assay because of the lack of extraction and dilution of the enzyme and the high substrate concentration in the analyzed volume. Lastly, the measurements may be performed with high anatomical resolution.
In conclusion, this technology seems to be a powerful tool for monitoring some endogenous enzymes of mammalian brain tissue. It should prove to be useful for the in vivo neuropharmacological or neurotoxicological studies, and it opens up a field of investigation for the understanding ofbrain physiology and for the analysis of correlations between enzymatic activity and physiological, behavioral, or pathological situations. It can be used when in vitro studies are unable to give the desired information because the anatomical, physiological, or behavioral integrity of the biological system is a condition for answer to the initial question.
